HirschHHMartinoRWardKN, et al.
Fourth European conference on infections in leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis2013;
56: 258–266.
2.
BoothSWillanJWongH, et al. Regional outcomes of severe acute respiratory syndrome coronavirus 2 infection in hospitalised patients with haematological malignancy. Eur J Haematol. Epub ahead of print 16 June 2020. DOI: 10.1111/ejh.13469
3.
MalardFGenthonABrissotE, et al. COVID-19 outcomes in patients with hematologic disease. Bone Marrow Transplant. Epub ahead of print 6 May 2020. DOI: 10.1038/s41409-020-0931-4
4.
CookGJohn AshcroftAPrattG, et al.
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy. Br J Haematol2020;
190: 15–17.
5.
Government S. Coronavirus (COVID-19): shielding support and contacts – gov.scot. COVID-19 guidance,www.gov.scot/publications/covid-shielding (accessed 6 August 2020).
CancarevicITathineniPMalikBH.Coronavirus disease 2019 (COVID-19) in cancer patients. Cureus2020;
2019: 10–14.
8.
UsherKBhullarNJacksonD.Life in the pandemic: social isolation and mental health. J Clin Nurs2020;
29: 2756–2752.
9.
Brooks SK, Webster RK, Smith LEet al. The psychological impact of quarantine and how to reduce. London: King’s College London, 2020, pp.19–21.
10.
TerposEEngelhardtMCookG, et al.
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European myeloma network (EMN). Leukemia 2020; 34: 2000–2011.
11.
SeilerAJeneweinJ.Resilience in cancer patients. Front Psychiatry2019;
10: 208.
